Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 See also  




2 References  













ADB-5'Br-BUTINACA







Add links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  

ADB-5'Br-BUTINACA
Identifiers

  • N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-5-bromo-1-butylindazole-3-carboxamide

PubChem CID
ChemSpider
Chemical and physical data
FormulaC18H25BrN4O2
Molar mass409.328 g·mol−1
3D model (JSmol)

  • NC(=O)[C@@H](NC(=O)c1nn(CCCC)c2ccc(Br)cc21)C(C)(C)C

  • InChI=1S/C18H25BrN4O2/c1-5-6-9-23-13-8-7-11(19)10-12(13)14(22-23)17(25)21-15(16(20)24)18(2,3)4/h7-8,10,15H,5-6,9H2,1-4H3,(H2,20,24)(H,21,25)/t15-/m1/s1

  • Key:DIOILIVJIIJFPO-OAHLLOKOSA-N

ADB-5'Br-BUTINACA (ADB-B-5Br-INACA) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist which has been sold as a designer drug,[1] first detected in Philadelphia in the US in May 2022,[2] and subsequently found in South Korea,[3] Portugal and Sweden.[4] It is specifically listed as an illegal drug in Italy,[5] South Korea[6] and several states in the US,[7][8] and controlled under analogue legislation in various other jurisdictions.

See also

[edit]

References

[edit]
  1. ^ Deventer MH, Persson M, Norman C, Liu H, Connolly MJ, Daéid NN, McKenzie C, Gréen H, Stove CP (October 2023). "In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs". Drug Testing and Analysis. doi:10.1002/dta.3592. PMID 37903509. S2CID 264671035.
  • ^ "ADB-5'Br-BINACA" (PDF). CFSRE Chemistry Report. The Center for Forensic Science Research & Education.
  • ^ Kim J, Yum H, Kang S, Lee N, Song J, Park Y, Choe S, Park M (November 2023). "Comprehensive evaluation of drug cases in Seoul and its metropolitan areas - 2022". Forensic Science International. 353: 111877. doi:10.1016/j.forsciint.2023.111877. PMID 37989071. S2CID 265022768.
  • ^ "Yttrande enligt 13 § Lag (2011:111) om förstörande av vissa hälsofarliga missbrukssubstanser" [Opinion according to § 13 Act (2011:111) on the destruction of certain substances of abuse dangerous to health] (PDF) (in Swedish). The Public Health Authority.
  • ^ "Aggiornamento delle tabelle contenenti l'indicazione delle sostanze stupefacenti e psicotrope, di cui al decreto del Presidente della Repubblica 9 ottobre 1990, n. 309 e successive modificazioni e integrazioni. Inserimento nella Tabella I di nuove sostanze psicoattive. (23A01072)" [Update of the tables containing the indication of the substances narcotic and psychotropic drugs, referred to in the decree of the President of the Republic 9 October 1990, n. 309 and subsequent amendments e integrations. Inclusion of new substances in Table I psychoactive. (23A01072)] (in Italian). Italy: Ministry of Health. 13 February 2023.
  • ^ "˝에이디비-5'비알-부티나카˝ 등3종 임시마약류 지정예고" [Announcement of temporary designation of 3 types of narcotics, including “ADB-5 ‘BR-Butinaka’”]. Korean Food and Drug Daily News (in Korean).
  • ^ "18VAC110-20-322. Placement of chemicals in Schedule I." Administrative Code. Commonwealth of Virginia.
  • ^ "Section 19-03.1-05 - Schedule I, N.D. Cent. Code § 19-03.1-05". North Dakota Century Code.

    • Retrieved from "https://en.wikipedia.org/w/index.php?title=ADB-5%27Br-BUTINACA&oldid=1235976244"
    Categories: 
    ●Cannabinoids
     ●Designer drugs
     ●Bromoarenes
     ●Amides
     ●Tert-butyl compounds
     ●Indazolecarboxamides
     Hidden categories: 
    ●CS1 Swedish-language sources (sv)
     ●CS1 Italian-language sources (it)
     ●CS1 Korean-language sources (ko)
     ●Articles with short description
     ●Short description matches Wikidata
     ●Chemical articles without CAS registry number
     ●Articles without EBI source
     ●Chemical pages without DrugBank identifier
     ●Articles without KEGG source
     ●Articles without UNII source
     ●Drugs missing an ATC code
     ●Drugs with no legal status
     ●Articles containing unverified chemical infoboxes
      


    ●This page was last edited on 22 July 2024, at 06:21 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki